ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Gary · 0 0 0

Patient basic information Patient: Mr. Gary Walker) Nationality: Indonesia Diagnosis: Myocardial infarction Diagnostic hospital: H0C0 treatment: Intracellular therapy + medication Dates of hospitalization: 168 days Treatment cost: about 365,916 yuan Treatment effect: pain relief Describing the condition: Mr. Gary is from Indonesia and was diagnosed with Myocardial infarction locally.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, escort and on-site services throughout the treatment process. After 168 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard. Treatment results: Patient's final pain relief.

At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient and continued to track recovery through a remote follow-up system. 'Mr. Liu Gary has criticized the case as a typical case of cross-border suspected seriousness clinical cases.

Liu G4 is a multidisciplinary collaborative mechanism that has developed an intravenous treatment + drug program for myocardial infarction, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease clinics and a summary of how international medical services are regulated. (Figure from Liu G5 official news reports and medical scenarios)

印度尼西亚,心肌梗死,山东大学齐鲁医院,国际医疗,来华就医,中国医疗